Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study
- PMID: 35216811
- PMCID: PMC9213568
- DOI: 10.1016/j.biopsych.2021.11.026
Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study
Abstract
Background: Suicide is among the leading causes of death in children and adolescents. There are well-known risk factors of suicide, including childhood abuse, family conflicts, social adversity, and psychopathology. While suicide risk is also known to be heritable, few studies have investigated genetic risk in younger individuals.
Methods: Using polygenic risk score analysis, we examined whether genetic susceptibility to major psychiatric disorders is associated with suicidal behaviors among 11,878 children enrolled in the ABCD (Adolescent Brain Cognitive Development) Study. Suicidal ideation and suicide attempt data were assessed using the youth report of the Kiddie Schedule for Affective Disorders and Schizophrenia for DSM-5. After performing robust quality control of genotype data, unrelated individuals of European descent were included in analyses (n = 4344).
Results: Among 8 psychiatric disorders we examined, depression polygenic risk scores were associated with lifetime suicide attempts both in the baseline (odds ratio = 1.55, 95% CI = 1.10-2.18, p = 1.27 × 10-2) and in the follow-up year (odds ratio = 1.38, 95% CI = 1.08-1.77, p = 1.05 × 10-2), after adjusting for children's age, sex, socioeconomic backgrounds, family history of suicide, and psychopathology. In contrast, attention-deficit/hyperactivity disorder polygenic risk scores were associated with lifetime suicidal ideation (odds ratio = 1.15, 95% CI = 1.05-1.26, p = 3.71 × 10-3), suggesting a distinct contribution of the genetic risk underlying attention-deficit/hyperactivity disorder and depression on suicidal behaviors of children.
Conclusions: The largest genetic sample of suicide risk data in U.S. children suggests a significant genetic basis of suicide risk related to attention-deficit/hyperactivity disorder and depression. Further research is warranted to examine whether incorporation of genomic risk may facilitate more targeted screening and intervention efforts.
Keywords: ADHD; Adolescents; Children; Depression; Polygenic risk score; Suicide.
Copyright © 2021 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
All authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this article. RHP has received fees for consulting or service on scientific advisory boards for Genomind, Psy Therapeutics, Outermost Therapeutics, RID Ventures, and Takeda. He has received patent royalties from Massachusetts General Hospital. He holds equity in Psy Therapeutics and Outermost Therapeutics. In the past 3 years, RCK was a consultant for Datastat, Inc., Holmusk, RallyPoint Networks, Inc., and Sage Pharmaceuticals. He has stock options in Mirah, PYM, and Roga Sciences. MF has lifetime research support from Abbott Laboratories, Acadia Pharmaceuticals, Alkermes, Inc., American Cyanamid, Aspect Medical Systems, AstraZeneca, Avanir Pharmaceuticals, AXSOME Therapeutics, BioClinica, Inc, Biohaven, BioResearch, BrainCells Inc., Bristol-Myers Squibb, CeNeRx BioPharma, Cephalon, Cerecor, Clarus Funds, Clexio Biosciences, Clintara, LLC, Covance, Covidien, Eli Lilly and Company, EnVivo Pharmaceuticals, Inc., Euthymics Bioscience, Inc., Forest Pharmaceuticals, Inc., FORUM Pharmaceuticals, Ganeden Biotech, Inc., Gentelon, LLC, GlaxoSmithKline, Harvard Clinical Research Institute, Hoffman-LaRoche, Icon Clinical Research, Indivior, i3 Innovus/Ingenix, Janssen R&D, LLC, Jed Foundation, Johnson & Johnson Pharmaceutical Research & Development, Lichtwer Pharma GmbH, Lorex Pharmaceuticals, Lundbeck Inc., Marinus Pharmaceuticals, MedAvante, Methylation Sciences Inc, Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia & Depression), National Center for Complementary and Alternative Medicine, National Coordinating Center for Integrated Medicine, National Institute on Drug Abuse, National Institutes of Health, National Institute of Mental Health, Neuralstem, Inc., NeuroRx, Novartis AG, Organon Pharmaceuticals, Otsuka Pharmaceutical Development, Inc., PamLab, LLC., Pfizer Inc., Pharmacia-Upjohn, Pharmaceutical Research Associates., Inc., Pharmavite LLC, PharmoRx Therapeutics, Photothera, Premiere Research International, Protagenic Therapeutics, Inc., Reckitt Benckiser, Relmada Therapeutics Inc., Roche Pharmaceuticals, RCT Logic, LLC (formerly Clinical Trials Solutions, LLC), Sanofi-Aventis US LLC, Shenox Pharmaceuticals, LLC, Shire, Solvay Pharmaceuticals, Inc., Stanley Medical Research Institute, Synthélabo, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Tal Medical, VistaGen, and Wyeth-Ayerst Laboratories. He also has equity holdings at Compellis and Psy Therapeutics. All other authors report no biomedical financial interests or potential conflicts of interest.
Figures



Comment in
-
Genetic Vulnerability for Preadolescent Suicidal Thoughts and Behaviors.Biol Psychiatry. 2022 Aug 1;92(3):e17-e18. doi: 10.1016/j.biopsych.2022.05.019. Biol Psychiatry. 2022. PMID: 35835506 Free PMC article. No abstract available.
Similar articles
-
Associations Between Genetic Risk for Adult Suicide Attempt and Suicidal Behaviors in Young Children in the US.JAMA Psychiatry. 2022 Oct 1;79(10):971-980. doi: 10.1001/jamapsychiatry.2022.2379. JAMA Psychiatry. 2022. PMID: 36044238 Free PMC article.
-
Association of Genome-Wide Polygenic Scores for Multiple Psychiatric and Common Traits in Preadolescent Youths at Risk of Suicide.JAMA Netw Open. 2022 Feb 1;5(2):e2148585. doi: 10.1001/jamanetworkopen.2021.48585. JAMA Netw Open. 2022. PMID: 35188556 Free PMC article.
-
Polygenic risk scores in relation to suicidality among youth with or at risk for bipolar disorder.J Affect Disord. 2025 Apr 15;375:44-48. doi: 10.1016/j.jad.2025.01.032. Epub 2025 Jan 10. J Affect Disord. 2025. PMID: 39800071
-
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2022 Jul 1;79(7):718-726. doi: 10.1001/jamapsychiatry.2022.1256. JAMA Psychiatry. 2022. PMID: 35612875 Free PMC article.
-
Risk factors of suicidal spectrum behaviors in adults and adolescents with attention-deficit / hyperactivity disorder - a systematic review.BMC Psychiatry. 2023 Aug 21;23(1):612. doi: 10.1186/s12888-023-05099-8. BMC Psychiatry. 2023. PMID: 37605105 Free PMC article.
Cited by
-
Understanding the causal relationships of attention-deficit/hyperactivity disorder with mental disorders and suicide attempt: a network Mendelian randomisation study.BMJ Ment Health. 2023 Jul;26(1):e300642. doi: 10.1136/bmjment-2022-300642. BMJ Ment Health. 2023. PMID: 37669871 Free PMC article.
-
Predicting adolescent psychopathology from early life factors: A machine learning tutorial.Glob Epidemiol. 2024 Aug 29;8:100161. doi: 10.1016/j.gloepi.2024.100161. eCollection 2024 Dec. Glob Epidemiol. 2024. PMID: 39279846 Free PMC article.
-
The Predictive Value of Preadolescent Suicidal Ideation Reporter Discrepancies in the ABCD Study.Child Psychiatry Hum Dev. 2025 Jan 17. doi: 10.1007/s10578-024-01806-y. Online ahead of print. Child Psychiatry Hum Dev. 2025. PMID: 39821510
-
Peripheral biological correlates of suicidality in children and adolescents: A systematic review and meta-analysis.iScience. 2025 Mar 25;28(4):112290. doi: 10.1016/j.isci.2025.112290. eCollection 2025 Apr 18. iScience. 2025. PMID: 40264798 Free PMC article.
-
Genetic risk, parental history, and suicide attempts in a diverse sample of US adolescents.Front Psychiatry. 2022 Sep 14;13:941772. doi: 10.3389/fpsyt.2022.941772. eCollection 2022. Front Psychiatry. 2022. PMID: 36186872 Free PMC article.
References
-
- Xu J, Murphy SL, Kockanek KD, Arias E (2020): Mortality in the United States, 2018. NCHS Data Brief, no. 355. Hyattesville, MD: National Center for Health Statistics. - PubMed
-
- World Health Organization (2014): Global Health Estimates 2013: Deaths by Cause, Age and Sex, Estimates for 2000–2012. Geneva: World Health Organization.
-
- World Health Organization: WHO Suicide data. Available at: https://www.who.int/data/gho/data/themes/mental-health/suicide-rates. Accessed February 7, 2022.
-
- Appleby L, Kapur N, Shaw J, Rodway C, Turnbull P, Ibrahim S, et al. (2017): Suicide by children and young people. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester.
-
- Hawton K, Bale L, Brand F, Townsend E, Ness J, Waters K, et al. (2020): Mortality in children and adolescents following presentation to hospital after non-fatal self-harm in the Multicentre Study of Self-harm: A prospective observational cohort study. Lancet Child Adolesc Health 4:111–120. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA041025/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- R01 MH116037/MH/NIMH NIH HHS/United States
- R01 MH119243/MH/NIMH NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- R00 MH101367/MH/NIMH NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical